Microbot Medical Inc.

NASDAQ: MBOT · Real-Time Price · USD
3.13
0.00 (0.00%)
At close: Aug 15, 2025, 9:58 AM

Microbot Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 84K n/a n/a n/a 142K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
12K 15K 42K 23K 14K 28K 35K 20K 26K 25K 33K 25K 23K 21K 28K 16K 14K 18K
Gross Profit
-12K -15K 42K -23K -14K -28K -35K -20K -26K -25K -33K -25K -23K -21K -28K -16K -14K -18K
Operating Income
-3.72M -3.02M -3.43M -3.3M -2.51M -2.38M -2.07M -2.54M -2.32M -2.92M -3.07M -3.47M -3.56M -3.18M -3.94M -2.55M -2.48M -2.39M
Interest Income
n/a 104K 38K 85K 46K 13K n/a 98K 37K n/a 75K 6K 50K n/a n/a n/a n/a n/a
Pretax Income
-3.5M -2.6M -3.39M -3.21M -2.46M -2.37M -3.15M -2.45M -2.29M -2.85M -3M -3.47M -3.51M -3.19M -3.86M -2.56M -2.51M -2.39M
Net Income
-3.5M -2.6M -3.39M -3.21M -2.46M -2.37M -3.15M -2.45M -2.29M -2.85M -3M -3.47M -3.51M -3.19M -3.86M -2.56M -2.51M -2.39M
Selling & General & Admin
1.61M 1.56M 1.45M 1.24M 1.09M 1.22M 938K 932K 959K 1.3M 1.41M 1.52M 1.37M 1.47M 1.89M 1.16M 1.09M 1.27M
Research & Development
2.1M 1.46M 1.98M 2.06M 1.42M 1.14M 1.13M 1.61M 1.36M 1.62M 1.88M 1.95M 2.19M 1.71M 2.26M 1.39M 1.39M 1.12M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 112K n/a n/a n/a
Operating Expenses
3.71M 3.02M 3.43M 3.3M 2.51M 2.36M 2.07M 2.54M 2.32M 2.92M 3.07M 3.47M 3.56M 3.18M 3.94M 2.55M 2.48M 2.39M
Interest Expense
n/a n/a n/a n/a n/a n/a 66K n/a n/a n/a 7K n/a n/a n/a n/a 3K n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 224K n/a n/a n/a 206K n/a n/a n/a
Cost & Expenses
3.72M 3.02M 3.43M 3.3M 2.51M 2.38M 2.07M 2.54M 2.32M 2.92M 3.07M 3.47M 3.56M 3.18M 3.94M 2.55M 2.48M 2.39M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
36.49M 17.02M 17.02M 16.47M 14.85M 14.06M 12.13M 11.71M 9.2M 7.92M 7.72M 7.11M 7.11M 7.11M 7.11M 7.11M 7.11M 7.11M
Shares Outstanding (Diluted)
36.49M 17.02M 17.02M 16.47M 14.85M 14.06M 12.13M 11.71M 9.2M 8.01M 7.72M 7.11M 7.11M 7.11M 7.11M 7.11M 7.11M 7.11M
EPS (Basic)
-0.1 0.01 -0.2 -0.2 -0.17 -0.17 -0.26 -0.21 -0.25 -0.36 -0.39 -0.49 -0.49 -0.45 -0.54 -0.36 -0.35 -0.34
EPS (Diluted)
-0.1 0.01 -0.2 -0.2 -0.17 -0.17 -0.26 -0.21 -0.25 -0.36 -0.39 -0.49 -0.49 -0.45 -0.54 -0.36 -0.35 -0.34
EBITDA
-3.49M -2.59M -3.4M -3.28M -2.5M -2.36M -2.31M -2.52M -2.3M -2.89M -3.04M -3.45M -3.54M -3.15M -3.91M -2.54M -2.46M -2.37M
EBIT
-3.5M -2.6M -3.43M -3.3M -2.51M -2.38M -2.35M -2.54M -2.32M -2.92M -3.07M -3.47M -3.56M -3.18M -3.94M -2.55M -2.48M -2.39M
Depreciation & Amortization
12K 15K 26K 23K 14K 28K 35K 20K 26K 25K 33K 25K 23K 21K 28K 16K 14K 18K